Mml Investors Services, LLC Gilead Sciences, Inc. Transaction History

Mml Investors Services, LLC

$27.4 Billion
Q3 2024

A detailed history of Mml Investors Services, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mml Investors Services, LLC holds 190,689 shares of GILD stock, worth $17.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

190,689

Previous 168,498 13.17%

Holding current value

$17.7 Million

Previous $11.6 Million 38.28%

% of portfolio

0.06%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$66.59 - $83.99 $1.48 Million - $1.86 Million	22,191 Added 13.17%	190,689 $16 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $611,165 - $705,332	-9,678 Reduced 5.43%	168,498 $11.6 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $1.35 Million - $1.64 Million	-18,834 Reduced 9.56%	178,176 $13.1 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $1.09 Million - $1.23 Million	14,854 Added 8.15%	197,010 $16 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $411,032 - $448,444	-5,559 Reduced 2.96%	182,156 $13.7 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $84,751 - $96,670	-1,115 Reduced 0.59%	187,715 $14.5 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $3.18 Million - $3.63 Million	-41,158 Reduced 17.9%	188,830 $15.7 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $1.02 Million - $1.46 Million	16,340 Added 7.65%	229,988 $19.7 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $643,329 - $734,848	10,805 Added 5.33%	213,648 $13.2 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $1.4 Million - $1.57 Million	24,213 Added 13.55%	202,843 $12.5 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $845,574 - $1.06 Million	14,599 Added 8.9%	178,630 $10.6 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $191,460 - $217,311	2,951 Added 1.83%	164,031 $11.9 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $1.22 Million - $1.32 Million	18,080 Added 12.64%	161,080 $11.3 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $182,793 - $199,727	2,880 Added 2.06%	143,000 $9.85 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $684,900 - $781,470	11,415 Added 8.87%	140,120 $9.06 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $254,925 - $290,475	-4,500 Reduced 3.38%	128,705 $7.5 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $2.05 Million - $2.58 Million	33,089 Added 33.05%	133,205 $8.42 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $1.3 Million - $1.51 Million	-17,969 Reduced 15.22%	100,116 $7.7 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $1.28 Million - $1.64 Million	20,491 Added 21.0%	118,085 $8.83 Million
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $307,422 - $338,154	4,989 Added 5.39%	97,594 $6.34 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $1.93 Million - $2.13 Million	30,862 Added 49.98%	92,605 $5.87 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $119,718 - $134,250	1,935 Added 3.24%	61,743 $4.17 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $442,774 - $496,024	7,081 Added 13.43%	59,808 $3.89 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $295,435 - $385,520	-4,880 Reduced 8.47%	52,727 $3.3 Million
Q3 2018 Nov 07, 2018	BUY	$71.28 - $78.92 $944,032 - $1.05 Million	13,244 Added 29.85%	57,607 $4.45 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $94,335 - $110,038	1,454 Added 3.39%	44,363 $3.14 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $501,649 - $611,565	-6,887 Reduced 13.83%	42,909 $3.24 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $246,463 - $289,313	3,464 Added 7.48%	49,796 $3.57 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $3.34 Million - $3.96 Million	46,332	46,332 $3.75 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Account

Mml Investors Services, LLC Gilead Sciences, Inc. Transaction History